Investigating how diabetes medications affect cognitive health and Alzheimer's risk
Association of cumulative exposure to metformin and other T2D medications with cognitive impairment and AD/ADRD biomarkers
This study is looking at how diabetes medications like metformin might affect brain health and the risk of Alzheimer's disease over time, helping us understand if these meds could also be useful for preventing memory problems in people with diabetes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10924058 on NIH RePORTER |
What this research studies
This research examines the long-term effects of diabetes medications, particularly metformin, on cognitive function and the risk of Alzheimer's disease. By analyzing data from participants in the Diabetes Prevention Program, the study aims to understand how these medications may influence brain health over time. Researchers will assess cognitive impairment and related biomarkers using advanced imaging techniques and blood tests. This could provide valuable insights into the potential repurposing of diabetes medications for Alzheimer's prevention.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with type 2 diabetes who are concerned about cognitive health and Alzheimer's risk.
Not a fit: Patients without a diagnosis of type 2 diabetes or those not at risk for Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing cognitive decline and Alzheimer's disease in patients with diabetes.
How similar studies have performed: Previous research has shown promising results in exploring the effects of diabetes medications on cognitive health, making this study a continuation of that investigation.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Luchsinger, Jose Alejandro — Columbia University Health Sciences
- Study coordinator: Luchsinger, Jose Alejandro
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.